| Prev Close | 193.09 |
| Day Low/High | 194.50 / 199.78 |
| 52 Wk Low/High | 187.16 / 468.55 |
Biogen Inc. (BIIB)
199.65
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 146.45B |
| Market Cap | 28.28B |
| P/E Ratio | 8.89 |
| Div & Yield | N.A. (N.A) |
Two Giants Blindsided by Major Trends
McDonald's and GlaxoSmithKline are fighting against major turns of the tide.
Taking a Shot at a Monitise Long
This may be one of only two technical buying opportunities in 2014.
The Lesson of Today's Session
Become more aggressive about the real valuations of companies.
No Joy in Shortville
Shorts take much more homework than longs.
Biotechs Flash the Green Light
After a decline, the sector has built a base, and these names are breaking out.
In Fact, There Is No Bubble, Part 4
Away from the techs and the biotechs, you will find an astounding uniformity among stocks.
Fitz Bits: Be a Blank Slate
Take a step back from the noise and use only what you see on the charts.
The Blueprints for this Market (Part 5)
When it gets as bad as it is now, we tend not to even care if a company is profitable.
Miracle Drug May Be Ailing Gilead
Its potent hepatitis C treatment is not a boon for shareholders.
Scoping the Earnings Trades
Not seeing much on Biogen, but Yum! Brands looks playable.
Netflix and Allergan Lead the Way
Internet and biotech stocks are trading as a cohort right now.
Get Used to the New Market Reality
Algos think faster and react faster than humans can.
A Blueprint for Highflier Stability
Cautionary tales that the IPO window might be closing at last.
Fitz Bits: The Biotech Wreck
These stocks are broken -- and you can't un-break them
Henry Gambell Analysis: E-mini S&P, VIX, CELG, BIIB, GLD, SLV & XME
Today's Big Idea covers resistance in the S&P along with key signals in the VIX, and update on CELG and thoughts on precious metals and fresh signals in XME.
A Surprising Leaderboard
These sectors have shown some fight.
The Tyranny of Futures Goes Away
And valuation of individual stocks comes back into play.
I'll Still Trumpet These Stocks
I like living, breathing examples of growth stocks going right.
Three Plays on the Table
I'm using the market's push lower to buy strong charts.
Who's Getting Busy Living?
These types of companies are winners today.
Healthcare Holding Strong
It's clear that bulls in this sector aren't weak hands.
Giving Biogen Another Go
Here's what we'd need to see before trying a reentry.
Why Tech Works
There are quite a few reasons to be optimistic.
A Healthy Trade in Biogen
I'm looking at it closely for a buy entry.
